Resurface Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$50K
- Investors
-
1
Resurface Therapeutics General Information
Description
Developer of a drug discovery platform designed to identify and develop therapies for cancer. The company focuses on identifying novel targets and developing small molecule drugs, enabling healthcare providers to offer improved treatment options for patients with oncological conditions.
Contact Information
Website
www.resurfacetherapeutics.comCorporate Office
- Duxbury, MA
- United States
Corporate Office
- Duxbury, MA
- United States
Resurface Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 16-Sep-2026 | $50K | Completed | Startup |
Resurface Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Standish Spring Investments | Venture Capital | Minority |
Resurface Therapeutics FAQs
-
Where is Resurface Therapeutics headquartered?
Resurface Therapeutics is headquartered in Duxbury, MA.
-
What industry is Resurface Therapeutics in?
Resurface Therapeutics’s primary industry is Drug Discovery.
-
Is Resurface Therapeutics a private or public company?
Resurface Therapeutics is a Private company.
-
What is Resurface Therapeutics’s current revenue?
The current revenue for Resurface Therapeutics is .
-
How much funding has Resurface Therapeutics raised over time?
Resurface Therapeutics has raised $50K.
-
Who are Resurface Therapeutics’s investors?
Standish Spring Investments has invested in Resurface Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process